<p>Correlation between DNA methylation status (average β-values) and recurrence was examined in 145 samples of tumorous tissue (<b>A</b>) and 145 samples of the corresponding non-cancerous lung tissue (<b>B</b>) obtained from patients with lung adenocarcinomas who had undergone complete resection and had not received any adjuvant therapy after surgery. All of the examined 26,455 probes of the Infinium array are shown along the chromosomes. Red color means that higher β-values of the probes were observed in recurrence-positive patients than in recurrence-negative patients (<i>P</i><0.001). Blue color means that lower β-values of the probes were observed in recurrence-positive patients than in recurrence-negative patients (<i>P</i><0.001).</p
The identification of molecular markers in negative surgical margins of oral squamous cell carcinoma...
BACKGROUND:Aberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases o...
Background: Lung adenocarcinoma (LUAD) is the leading cause of cancer-related mortality worldwide. M...
<div><p>The aim of this study was to clarify the significance of DNA methylation alterations at prec...
The aim of this study was to clarify the significance of DNA methylation alterations at precancerous...
<p>DNA methylation is associated with subsequent tumor recurrence within 24 months for patients with...
Accumulating evidence has suggested the requirement for further stratification of patients in the sa...
Accumulating evidence has suggested the requirement for further stratification of patients in the sa...
BACKGROUND: Aberrant methylation of CpG islands acquired in tumor cells in promoter regions is one c...
BackgroundDespite optimal and early surgical treatment of non-small-cell lung cancer (NSCLC), many p...
We lack tools to risk-stratify triple-negative breast cancer (TNBC). Our goal was to develop molecul...
The use, distribution or reproduction in other forums is permitted, provided the original author(s) ...
<p>DNA methylation levels (average β-values) (<b>A</b>) and mRNA expression levels (<b>B</b>) for th...
<p>Supp Fig 1 Methylation difference between recurrence vs initial. Log fold-change of methylation d...
It is known that the violation of DNA methylation processes is one of the earliest and most common e...
The identification of molecular markers in negative surgical margins of oral squamous cell carcinoma...
BACKGROUND:Aberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases o...
Background: Lung adenocarcinoma (LUAD) is the leading cause of cancer-related mortality worldwide. M...
<div><p>The aim of this study was to clarify the significance of DNA methylation alterations at prec...
The aim of this study was to clarify the significance of DNA methylation alterations at precancerous...
<p>DNA methylation is associated with subsequent tumor recurrence within 24 months for patients with...
Accumulating evidence has suggested the requirement for further stratification of patients in the sa...
Accumulating evidence has suggested the requirement for further stratification of patients in the sa...
BACKGROUND: Aberrant methylation of CpG islands acquired in tumor cells in promoter regions is one c...
BackgroundDespite optimal and early surgical treatment of non-small-cell lung cancer (NSCLC), many p...
We lack tools to risk-stratify triple-negative breast cancer (TNBC). Our goal was to develop molecul...
The use, distribution or reproduction in other forums is permitted, provided the original author(s) ...
<p>DNA methylation levels (average β-values) (<b>A</b>) and mRNA expression levels (<b>B</b>) for th...
<p>Supp Fig 1 Methylation difference between recurrence vs initial. Log fold-change of methylation d...
It is known that the violation of DNA methylation processes is one of the earliest and most common e...
The identification of molecular markers in negative surgical margins of oral squamous cell carcinoma...
BACKGROUND:Aberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases o...
Background: Lung adenocarcinoma (LUAD) is the leading cause of cancer-related mortality worldwide. M...